Educational Intervention to Increase Select Guideline-recommended Cardioprotective Medications in Patients With Diabetes

NAUnknownINTERVENTIONAL
Enrollment

4,197

Participants

Timeline

Start Date

August 18, 2021

Primary Completion Date

November 30, 2021

Study Completion Date

August 16, 2022

Conditions
Diabetes Mellitus, Type 2Cardiovascular Diseases
Interventions
OTHER

Educational Intervention

The educational intervention will involve guideline-based treatment recommendation information for providers via fax/mail and phone and provide resources via mail and phone for patients to learn more about ways to reduce their cardiovascular risk.

Trial Locations (1)

40202

Humana, Louisville

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Boehringer Ingelheim

INDUSTRY

collaborator

Humana Healthcare Research, Inc.

UNKNOWN

lead

Humana Inc.

INDUSTRY

NCT04862858 - Educational Intervention to Increase Select Guideline-recommended Cardioprotective Medications in Patients With Diabetes | Biotech Hunter | Biotech Hunter